Drug design by machine-trained elastic networks: predicting Ser/Thr-protein kinase inhibitors' activities. [electronic resource]
- Molecular diversity May 2021
- 899-909 p. digital
Publication Type: Journal Article
1573-501X
10.1007/s11030-020-10074-6 doi
Drug Design Machine Learning Models, Molecular Protein Kinase Inhibitors--chemistry Protein Serine-Threonine Kinases--antagonists & inhibitors Quantitative Structure-Activity Relationship Tumor Suppressor Proteins--antagonists & inhibitors